Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Sep-Oct;90(5):728-30.
doi: 10.1590/abd1806-4841.20153296.

Persistent docetaxel-induced supravenous erythematous eruption

Karina de Almeida Pinto Fernandes  1 , Paulo Antônio Oldani Felix  1
Affiliations
Case Reports

Persistent docetaxel-induced supravenous erythematous eruption

Karina de Almeida Pinto Fernandes et al. An Bras Dermatol. 2015 Sep-Oct.

Abstract

Taxanes are drugs used to treat many types of cancer, including breast and lung cancer. The most common side effects of these drugs are neutropenia and mucositis. Signs of skin toxicity are observed in about 65% of cases and include alopecia, hypersensitivity reactions, persistent supravenous erythematous eruption, nail changes, scleroderma reactions and others. We report two cases of skin reaction to docetaxel and warn that it is not necessary to interrupt the treatment in these cases.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

Figures

Figure 1
Figure 1
Brownish macule following the venous pathway on the upper left limb
Figure 2
Figure 2
Residual hyperpigmentation following venous pathway on the upper left limb
Figure 3
Figure 3
Erythematous-brownish macules on back of hand following venous pathway on the upper left limb
Figure 4
Figure 4
Complete remission of lesion 3 months after the end of chemotherapy
See this image and copyright information in PMC

References

    1. Donati A, Castro LG. Cutaneous adverse reactions to chemotherapy with taxanes: the dermatologist's point of view. An Bras Dermatol. 2011;86:755–758. - PubMed
    1. Criado PR, Brandt HR, Moure ER, Pereira GL, Sanches JA., Júnior Adverse mucocutaneous reactions related to chemotherapeutic agents: part II. An Bras Dermatol. 2010;85:591–608. - PubMed
    1. Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol. 1999;40:367–398. - PubMed
    1. Sanches JA, Junior, Brandt HR, Moure ER, Pereira GL, Criado PR. Adverse mucocutaneous reactions to chemotherapeutic agents: part I. An Bras Dermatol. 2010;85:425–437. - PubMed
    1. Aydogan I, Kavak A, Parlak AH, Alper M, Annakkaya AN, Erbas M. Persistent serpentine supravenous hyperpigmented eruption associated whit docetaxel. J Eur Acad Dermatol Venereol. 2005;19:345–347. - PubMed

Publication types

LinkOut - more resources